Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
5
×
deals
5
×
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
startups
boston top stories
cancer
new york top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
generic drugs
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
armo biosciences
clinical trials
drug prices
investing
scott gottlieb
What
drugs
5
×
bio
roundup
new
pharmaceutical
advance
ahead
aims
appetite
approach
asco
bails
based
biology
biotech
black
brand
branded
bread
bridgebio
butter
buyout
called
cancer
capital
car
cash
choices
commissioner
company
consumers
costly
counterweight
cytokine
debuts
develop
developing
diabetes
diamond’s
elevatebio
Language
unset
Current search:
biotech
×
deals
×
" boston blog main "
×
drugs
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs